Ocular Therapeut
(OCUL)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -145,118 | -108,625 | -64,848 | -80,736 | -51,516 |
| Depreciation Amortization | 2,835 | 1,876 | 920 | 2,983 | 2,025 |
| Accounts receivable | -4,056 | -4,053 | -367 | -4,854 | -2,264 |
| Accounts payable and accrued liabilities | -430 | -727 | 1,693 | 583 | -73 |
| Other Working Capital | -11,088 | -9,877 | -13,007 | -7,411 | -858 |
| Other Operating Activity | 62,609 | 62,717 | 41,722 | 19,201 | 4,906 |
| Operating Cash Flow | $-95,248 | $-58,689 | $-33,887 | $-70,234 | $-47,780 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,086 | -997 | -255 | -6,087 | -5,628 |
| Investing Cash Flow | $-1,086 | $-997 | $-255 | $-6,087 | $-5,628 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | 2,000 | 2,000 |
| Debt Issued | N/A | N/A | N/A | 82,474 | 82,474 |
| Debt Repayment | N/A | N/A | N/A | -26,125 | -26,125 |
| Common Stock Issued | 327,597 | 323,419 | 321,223 | 118,663 | 10,493 |
| Other Financing Activity | 0 | 0 | 0 | -7,184 | -7,184 |
| Financing Cash Flow | $327,597 | $323,419 | $321,223 | $169,828 | $61,658 |
| Beginning Cash Position | 197,571 | 197,571 | 197,571 | 104,064 | 104,064 |
| End Cash Position | 428,834 | 461,304 | 484,652 | 197,571 | 112,314 |
| Net Cash Flow | $231,263 | $263,733 | $287,081 | $93,507 | $8,250 |
| Free Cash Flow | |||||
| Operating Cash Flow | -95,248 | -58,689 | -33,887 | -70,234 | -47,780 |
| Capital Expenditure | -1,086 | -997 | -255 | -6,087 | -5,628 |
| Free Cash Flow | -96,334 | -59,686 | -34,142 | -76,321 | -53,408 |